Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/131339
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Design and synthesis of novel 4-substituted quinazoline-2-carboxamide derivatives targeting AcrB to reverse the bacterial multidrug resistance
Author: Gu, X.
Pisoni, L.A.
Wang, Y.
Song, D.
Sykes, M.J.
Qin, Y.
Semple, S.J.
Polyak, S.W.
Venter, H.
Ma, S.
Citation: Bioorganic Chemistry, 2020; 105:1-16
Publisher: Elsevier
Issue Date: 2020
ISSN: 0045-2068
1090-2120
Statement of
Responsibility: 
Xinjie Gu, Lily A. Pisoni, Yinhu Wang, Di Song, Matthew J. Sykes, Yinhui Qin ... et al.
Abstract: Novel 4-substituted quinazoline-2-carboxamide derivatives targeting AcrB were designed, synthesized and evaluated for their biological activity as AcrB inhibitors. In particular, the ability of the compounds to potentiate the activity of antibiotics, to inhibit Nile Red efflux and to target AcrB was investigated. In this study, 19 compounds were identified to reduce the MIC values of at least one tested antibacterial by 2- to 16-fold at a lower concentration. Identified modulating compounds also possessed considerable inhibition on Nile red efflux at concentrations as low as 50 µM and did not display off-target effects on the outer membrane. Among the above compounds with characteristics of ideal AcrB inhibitors, the most outstanding ones are A15 and B5-B7. In particular, A15 and B7 exhibited not only the most prominent performance in the synergistic effect, but also completely abolished Nile Red efflux at concentrations of 50 and 100 μM, respectively. In docking simulations, A15 was observed to have the most favorable docking score and was predicted to bind in the hydrophobic trap as has been noted with other inhibitors such as MBX2319. It is worth noting that the 4-morpholinoquinazoline-2-carboxamide core appears to be a promising chemical skeleton to be further optimized for the discovery of more potent AcrB inhibitors.
Keywords: AcrB
Antimicrobial resistance
Efflux pump inhibitor
Inhibition of efflux
Quinazoline
Rights: © 2020 Elsevier Inc. All rights reserved.
DOI: 10.1016/j.bioorg.2020.104394
Grant ID: http://purl.org/au-research/grants/nhmrc/1147538
Appears in Collections:Aurora harvest 4
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.